期刊选题

1、投稿方式：在线投稿。

2、官网网址：http://www.idi-cma.org

自动跳转至：

https://journals.lww.com/IDI/Pages/default.aspx

3、投稿网址：

https://www.editorialmanager.com/idi/default.aspx

4、官网邮箱：idi@cmaph.org；cma_idi@126.com

5、官网电话：010-51322080；010-51322086

6、出刊日期：季刊，逢季首月出版。

7、微信公众号：感染性疾病与免疫（IDI2021）

2021年9月2日星期四

《感染性疾病与免疫（英文）》面向全球征稿

（Infectious Diseases & Immunity）

【微信公众号“感染性疾病与免疫”信息】

感染性疾病与免疫 2021-05-24

【杂志简介】

《感染性疾病与免疫（英文）》（Infectious Diseases & Immunity）是由中国科协主管、中华医学会主办、中华医学会杂志社和荷兰威科集团（Wolters Kluwer）出版的专业学术期刊，于2019年入选“中国科技期刊卓越行动计划”高起点新刊项目。

本刊采取开放获取（Open Access）模式出版发行，为季刊，第一期已于2021年4月份正式上线。

【征稿主题】

1. 新发再发传染病；

2. HIV感染；

3. 细菌、真菌、脓毒症；

4. 病毒性肝炎；

5. 感染性疾病免疫学；

6. 医院感染及控制；

7. 免疫预防；

8. 公共卫生及流行病学

【投稿渠道】

投稿网址：

www.editorialmanager.com/idi

杂志官网：

www.idi-cma.org

邮箱：

idi@cmaph.org

电话：

010-5132 2080, 010-5132 2086

目前投稿免收稿件处理费，

欢迎相关领域的学者积极投稿！

《感染性疾病与免疫（英文）》作者须知

【官网信息】

Instructions for Authors

Aims and Scope

Infectious

Diseases & Immunity (IDI) is an open access, peer-reviewed journal.

It is supervised by Chinese Association for Science and Technology,

sponsored by Chinese Medical Association, and published in collaboration

with Wolters Kluwer.

IDI

covers the types of Original Article (Basic or Clinical), Consensus and

Guideline, Commentary, Editorial, Review, Short Report & Case

Report, Research Letter, Perspective, etc. The journal focuses on the

new developments in basic and clinical researches in the diagnosis and

treatment of infectious diseases and related immunology. It aims to

provide a platform of timely academic exchanges and information

transmission for scientists and clinical experts in related fields

around the world.

TYPES OF MANUSCRIPTS PUBLISHED

……

*Text

word count excludes abstract, figure legends, and references. Please

ensure that the text word count is included on the Title page of the

manuscript.

Editorials

are invited articles to explain the importance of specific articles or

to provide opinions on general concepts in practice, research or policy.

Editorials have no abstract and are typically 1000 to 1500 words long.

Editorials which discuss a recently published article should cite that

article as the first reference.

Consensuses

and Guidelines are official recommendations from professional

organizations on issues related to clinical practice and health care

delivery. IDI is flexible with length, reference, and other format

requirements given the variability in the format of guidelines developed

by different organizations. A concise table or concise graphic

summarizing the recommendations and other key points is desirable.

Guidelines that meet standards (http://www.equator-network.org/) will

fare more favorably than those that do not.

Perspectives

are welcomed and the length should be about 1500 words (not including

tables, figures, and references). Authors of this type of articles

should sign their real names; no anonymous pieces are published.

Original

Articles are full-length reports of completed basic, translational or

clinical research. Articles should report important, novel and fully

completed studies with strong conclusions.

Reviews

are comprehensive analyses of specific topics. They are submitted upon

invitation by the Editors. Proposals for reviews may be submitted;

however, in this case authors should only send an outline of the

proposed paper for initial consideration. Both solicited and unsolicited

review articles will undergo peer review prior to acceptance.

Research

Letters must offer perspective to content published in IDI. A Research

Letter must reference the original source, and a Response to a Letter

must reference the Letter in the first few paragraphs. Letters can use

an arbitrary title, but a Response must cite the title of the Letter:

e.g. Response to [title of Letter]. This ensures that readers can track

the line of discussion. Submissions may be edited for length,

grammatical correctness, and journal style. Authors will be asked to

approve editorial changes that alter the substance or tone of a letter

or response.

Commentaries,

upon Editor's invitation, discuss a paper published in a specific issue

and should set the problems addressed by the paper in the wider context

of the field. Proposals for Commentaries may be submitted; however, in

this case authors should only send an outline of the proposed paper for

initial consideration including the article discussed.

Short

Reports & Case Reports cover new observations of diseases, clinical

findings or novel/unique treatment outcomes relevant to practitioners

in infectious diseases and immunity research. The text should be

arranged as follows: Abstract, Introduction, Case Report, and

Discussion. Only cases of exceptional interest and novelty are

considered. For manuscripts that do not qualify, Editors may ask authors

to shorten manuscripts and rewrite as Letters to the Editor.

MANUSCRIPT PREPARATION AND FORMATTING INSTRUCTIONS

Please

double space the entire main body document and number each page. Do not

add line numbers as the system will generate those when the PDF is

built Acceptable document file types for text and tables include .DOC

and .DOCX; do not submit a PDF.

Cover

Letter: The cover letter must state that the manuscript has not been

and will not be considered for publication elsewhere and give a brief

introduction to the novel findings of this work, along with three or

more experts in the field as potential reviewers, but no more than three

excluded referees.

Title

Page: The Title Page must be a separate file and upload separately to

the main body file. The following elements are required for every

submission.

Type

of manuscript. Editorial, Consensus and Guideline, Perspective,

Original Article, Review, Research Letter, Commentary, Case Report.

Title.

Include a descriptive title of the work; the title should not be a

sentence. No proprietary or brand names for drugs or agents may be used

in article titles.

Authors.

The full first name, middle initials, and family name of each author,

as well as the name(s) of the department(s) and institution(s) to which

the work should be attributed.

Correspondence. A current email for the corresponding author must be provided.

Text word count. Text word count excludes abstract, figure legends, and references.

Abstract:

Where required, abstracts are limited to 500 words, which are excluded

from the overall manuscript word count. The abstract should briefly

describe: (1) the problem being addressed in the study, (2) how the

study was performed, (3) the salient results, and (4) what the authors

conclude from the results.

Key Words: Minimum 3 keywords needed; three to six keywords.

Introduction:

The introduction contains a statement of the purpose of the work, the

problem that it stimulated, and a brief summary of relevant published

investigations.

Materials

and Methods: Avoid detailed description of previously published methods

and cite the appropriate reference. Detailed methods may be provided as

Supplementary information.

Results: The results should be concise, avoiding redundant tables and figures illustrating the same data.

Discussion: This section should follow the results and is used to interpret results, with minimal recapitulation of findings.

Statistics:

Whenever possible quantify findings and present them with appropriate

indicators of measurement error or uncertainty (such as confidence

intervals). Authors should report losses to observation (such as

dropouts from a clinical trial). When data are summarized in the Results

section, specify the statistical methods used to analyze them. Avoid

non-technical uses of technical terms in statistics, such as ‘random'

(which implies a randomizing device), ‘normal', ‘significant',

‘correlations', and ‘sample'. Define statistical terms, abbreviations,

and most symbols. Specify the computer software used. Use upper italics

(e.g., P=0.048). For all P values include the exact value and not less

than 0.05 or 0.01. Mean differences in continuous variables, proportions

in categorical variables and relative risks including odds ratios and

hazard ratios should be accompanied by their confidence intervals.

Acknowledgments:

This section normally includes sources of research funds, the names of

collaborators who are not listed as coauthors, or of any others who

contributed to the manuscript. Where a medical writer or editorial

assistant has been used to write or edit the article, the writer must be

identified and named, together with the source of funding.

Funding:

Include disclosure of funding received for this work, especially

details of funding from any of the following organizations: National

Institutes of Health (NIH); Wellcome Trust; and Howard Hughes Medical

Institute (HHMI).

Author contributions: List each author's specific contributions to the work (see details below, under (Authorship).

Conflicts of Interest: List any potential conflict of interest for each author, or make a declaration of "None"

……

更多详情：

https://edmgr.ovid.com/idi/accounts/ifauth.htm